Lauren Véronèse

8PUBLICATIONS
58CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsGene expression (incl. microarray and other genome-wide approaches)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 11, 2026
Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study.

Gaspar Aspas Requena, Pau Montesinos, Emilie Bérard

|Aug 21, 2025
Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study.

Jules Higué, Corentin Orvain, Pierre-Yves Dumas

|May 31, 2024
Molecular landscape of mature B-cell lymphoproliferative disorders with BCL3-translocation: A Groupe Francophone de Cytogénétique Hématologique (GFCH)/French Innovative Leukemia Organization (FILO) study.

Lauren Véronèse, Hedi Bensaber, Louis-Thomas Dannus

|Apr 13, 2024
The t(X;20)(q13;q13) translocation is a good prognostic factor in myeloid neoplasms: A report of 25 cases from the Groupe Francophone de Cytogénétique Hématologique.

Florence Nguyen-Khac, Marc Muller, Elise Chapiro

|May 05, 2023
Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples.

Jasneet Kaur Khalsa, Justin Cha, Filippo Utro

|Apr 13, 2023
Optical Genome Mapping in Routine Cytogenetic Diagnosis of Acute Leukemia.

Gwendoline Soler, Zangbéwendé Guy Ouedraogo, Carole Goumy

Pageof 2

Frequent Collaborators

3 joint publications

Florence Nguyen-Khac

3 joint publications

Audrey Bidet

2 joint publications

Marie-Bérengère Troadec

2 joint publications

Christian Récher